Back

Beyond atrial fibrillation screening: characterizing other clinically relevant arrhythmias detected during 14-day electrocardiogram monitoring.

12 April 2026 (08:00 - 15:30)
Organised by: Logo
Congress Presentation Part of: Prevalence and incidence of atrial fibrillation Diagnostic Methods EHRA Premium Access EHRA 2026 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Emelie Rakai

Karolinska Institutet Danderyd Hospital, Stockholm (Sweden)

5 More presentations in this session

Presentation thumbnail
Dosimetric Predictors of New-Onset Atrial Fibrillation Following Thoracic Radiotherapy for Lung Cancer
Doctor H. Yalman (Istanbul, TR)
Abstract Slides Video
Presentation thumbnail
CHADSVASc score as a predictor of atrial fibrillation after cryptogenic stroke: implications for early anticoagulation
Doctor B. Brescia (Napoly, IT)
Abstract Slides Video
Presentation thumbnail
Biomarkers in atrial fibrillation: insights from the ACaSA study
Doctor V. Bilgeri (Innsbruck, AT)
Abstract Slides Video
Presentation thumbnail
Supine hypertension as a predictor of atrial fibrillation: a UK biobank cohort study
Assistant Professor K. Lee (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Atrial fibrillation reporting with semaglutide versus tirzepatide in eudravigilance: a comparative disproportionality analysis
Doctor Y. Shhab (Bucharest, RO)
Abstract Slides Video

Access the full session

Session thumbnail
Prevalence and incidence of atrial fibrillation

The Event

Event poster

EHRA 2026

12 April - 14 April 2026
You may be interested in
thumbnail
Congress Session
Atrial fibrillation miscellaneous
thumbnail
Congress Session
Late-Breaking Science: clinical
thumbnail
Congress Session
Registries on atrial fibrillation and sudden death

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources